Tag: Field Trip

Dave HodesJuly 14, 2022
shutterstock_135117653-1.jpg

8min00
The psychedelics industry today has focused mostly on finding, patenting, and taking to clinical trials some version of a psychedelic substance.  But now that these substances are going deeper into clinical trials than ever before, the goals that researchers are working to achieve within a relatively straightforward biotech development cycle are to make psychedelics less […]

Debra BorchardtApril 29, 2022
FieldTrip.jpg

7min00
Field Trip Health Ltd. (NASDAQ: FTRP) announced that its board approved a reorganization that will result in the separation of its Field Trip Discovery and Field Trip Health divisions into two independent public companies. Field Trip Discovery will be renamed Reunion Neuroscience Inc. and Field Trip Health will be renamed Field Trip Health and Wellness […]

Dave HodesApril 5, 2022
Sublingual-Ketamine-1-1280x853.jpg

8min00
Most people in the psychedelics industry believe that the growing superstar of psychedelic medicines is psilocybin—the “psychedelic du jour” as one scientist put it to Psychedelia. But ketamine is quickly changing that perception. Ketamine was introduced to the market in 1970 as a U.S. Food and Drug Administration (FDA) approved anesthetic after clinical trials that […]

Dave HodesMarch 2, 2022
shutterstock_266222585-scaled.jpg

8min00
A psychedelic experience can be very gratifying, and indeed, profoundly life-changing. As the demand grows for having such an experience, new ways to go on that journey in a safe and complete manner outside of a clinical trial have emerged. These are not the psychedelic retreats in places like The Netherlands and Jamaica and other […]

StaffFebruary 15, 2022
FieldTrip.jpg

3min00
Field Trip Health Ltd. (NASDAQ: FTRP) reported its third fiscal quarter 2022 results for the three months ending December 31, 2021 and gave a business update. Field Trip reported that it had earned patient services revenues of $1,360,811, an increase of 50% over the prior quarter and 330% year over year. The company also noted […]

Debra BorchardtJanuary 11, 2022
shutterstock_1758241817.jpg

4min00
Field Trip Health Ltd. (NASDAQ: FTRP) announced that the U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance for Field Trip’s patent application No. 17/364,047 for claims related to FT-104 (informally known as “Isoprocin Glutarate”), Field Trip’s first novel psychedelic molecule in development. FT-104 is being developed as a more efficient treatment […]

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.

 Sign up


About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.